99%+ PURITY VERIFIED·INDEPENDENT LAB TESTING·SHIPS WITHIN CANADA·DISCREET EXPRESS DELIVERY
JA Performance Peptides
JA Performance
Peptides
Back to Protocols
Single Peptide100 mcg

IGF-1 LR3 (100 mcg Vial)

Dosing & reconstitution protocol

Quick Reference

VIAL SIZE0.1 mg (100 mcg)
RECONSTITUTION1.0 mL bacteriostatic water
CONCENTRATION100 mcg/mL (1 mcg per unit)
ROUTESubcutaneous injection
FREQUENCYOnce daily
CYCLE LENGTH6–8 weeks
DOSE RANGE20–50 mcg/day
STORAGE−20 °C lyophilized / 2–8 °C reconstituted

Overview

IGF-1 LR3 has a 20–30 hour half-life due to reduced IGFBP binding. At 100 mcg/mL, 1 unit = 1 mcg. Keep a fast-acting carbohydrate on hand — it can lower blood glucose. Never exceed 50–60 mcg/day.

Dosing & Reconstitution Guide

PhaseDaily DoseUnitsVolume
Weeks 1–220 mcg20 units0.20 mL
Weeks 3–430–40 mcg30–40 units0.30–0.40 mL
Weeks 5–840–50 mcg40–50 units0.40–0.50 mL

Reconstitution Instructions

1.

Draw 1.0 mL bacteriostatic water with a sterile syringe.

2.

Inject slowly down the vial wall; avoid foaming.

3.

Gently swirl/roll until dissolved (do not shake).

4.

Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Supplies Needed

  • Peptide Vials (IGF-1 LR3, 0.1 mg): 15–25 vials
  • Insulin Syringes (U-100): 56 syringes
  • Bacteriostatic Water (10 mL): 3 bottles
  • Alcohol Swabs: 112 swabs

Dosing Protocol

Schedule

Once daily subcutaneously. Keep fast-acting carbohydrate on hand (can lower blood glucose).

Cycle Structure

6–8 weeks on, then 4–8 weeks off to prevent receptor desensitisation.

Timing

Any consistent time daily. Never exceed 50–60 mcg/day.

Storage & Handling

Important Notes